KC
GRNA

Kepos Capital’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Kepos Capital’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-59,000
Closed -$568K – 613
2022
Q1 		$568K Sell
59,000
-416,000
-88% -$4M 0.04% 215
2021
Q4 		$4.71M Buy
475,000
+250,000
+111% +$2.48M 0.39% 111
2021
Q3 		$2.23M Buy
225,000
+96,502
+75% +$954K 0.15% 252
2021
Q2 		$1.26M Buy
+128,498
New +$1.26M 0.09% 253